Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 22.03% is in line with its 5-year average of 21.37%, around the middle of its 5-year range (15.55%–27.35%).
0.67% above its 12-month average of 21.88%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 25.18%.
OPERATING MARGIN
22.03%
OPERATING MARGIN AVG TTM
21.88%
OPERATING MARGIN AVG 3Y
21.83%
OPERATING MARGIN AVG 5Y
21.37%
OPERATING MARGIN AVG 10Y
21.61%
OPERATING MARGIN AVG 15Y
20.66%
OPERATING MARGIN AVG 20Y
21.14%
CURRENT VS TTM AVG
+0.67%
CURRENT VS 3Y AVG
+0.91%
CURRENT VS 5Y AVG
+3.09%
CURRENT VS 10Y AVG
+1.95%
CURRENT VS 15Y AVG
+6.65%
CURRENT VS 20Y AVG
+4.19%
SECTOR MEDIAN · HEALTHCARE
14.90%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+47.85%
vs the sector median at left
Stryker Corporation
Market Cap
$105.47B
Operating Margin
22.03%
TTM Avg
21.88%
3Y Avg
21.83%
5Y Avg
21.37%
Market Cap
$102.40B
Operating Margin
1.62%
TTM Avg
1.41%
3Y Avg
1.42%
5Y Avg
1.37%
Market Cap
$92.60B
Operating Margin
15.48%
TTM Avg
15.38%
3Y Avg
15.15%
5Y Avg
15.20%
Market Cap
$89.12B
Operating Margin
3.51%
TTM Avg
4.55%
3Y Avg
4.90%
5Y Avg
5.40%
Market Cap
$128.81B
Operating Margin
28.27%
TTM Avg
24.24%
3Y Avg
21.84%
5Y Avg
19.75%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Stryker Corporation (SYK) | $105.47B | 22.03% | 21.88% | 21.83% | 21.37% |
| McKesson Corporation (MCK)vs › | $102.40B | 1.62% | 1.41% | 1.42% | 1.37% |
| Sanofi (SNY)vs › | $102.00B | 14.74% | 18.46% | 19.67% | 22.87% |
| GSK plc (GSK)vs › | $100.62B | 20.72% | 19.17% | 20.63% | 20.79% |
| CVS Health Corp. (CVS)vs › | $113.35B | 2.00% | 2.43% | 2.79% | 3.48% |
| Medtronic plc (MDT)vs › | $117.93B | 18.08% | 17.77% | 17.25% | 17.00% |
| HCA Healthcare, Inc. (HCA)vs › | $92.60B | 15.48% | 15.38% | 15.15% | 15.20% |
| Elevance Health Inc. (ELV)vs › | $89.12B | 3.51% | 4.55% | 4.90% | 5.40% |
| Bristol-Myers Squibb Company (BMY)vs › | $128.81B | 28.27% | 24.24% | 21.84% | 19.75% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $129.02B | 38.59% | 18.66% | 31.09% | 34.52% |
Gross Margin
65.2%
Operating Margin
22.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 25.18% |
| 2026-03-31 | 15.55% |
| 2025-12-31 | 27.35% |
| 2025-09-30 | 18.74% |
| 2025-06-30 | 22.60% |
| 2025-03-31 | 20.10% |
| 2024-12-31 | 25.84% |
| 2024-09-30 | 21.99% |
| 2024-06-30 | 21.36% |
| 2024-03-31 | 19.13% |
| 2023-12-31 | 24.51% |
| 2023-09-30 | 20.19% |
| 2023-06-30 | 21.30% |
| 2023-03-31 | 17.96% |
| 2022-12-31 | 22.97% |
| 2022-09-30 | 18.96% |
| 2022-06-30 | 20.16% |
| 2022-03-31 | 18.34% |
| 2021-12-31 | 23.19% |
| 2021-09-30 | 21.54% |
| 2021-06-30 | 21.82% |
| 2021-03-31 | 18.42% |
| 2020-12-31 | 25.72% |
| 2020-09-30 | 24.59% |
| 2020-06-30 | 7.53% |
| 2020-03-31 | 19.90% |
| 2019-12-31 | 25.10% |
| 2019-09-30 | 20.96% |
| 2019-06-30 | 22.47% |
| 2019-03-31 | 20.82% |
| 2018-12-31 | 24.13% |
| 2018-09-30 | 21.38% |
| 2018-06-30 | 22.37% |
| 2018-03-31 | 21.47% |
| 2017-12-31 | 21.98% |
| 2017-09-30 | 21.06% |
| 2017-06-30 | 21.58% |
| 2017-03-31 | 21.08% |
| 2016-12-31 | 22.87% |
| 2016-09-30 | 21.78% |
| 2016-06-30 | 17.61% |
| 2016-03-31 | 20.80% |
| 2015-12-31 | 23.87% |
| 2015-09-30 | 15.62% |
| 2015-06-30 | 17.64% |
| 2015-03-31 | 17.07% |
| 2014-12-31 | 17.88% |
| 2014-09-30 | 18.84% |
| 2014-06-30 | 12.99% |
| 2014-03-31 | 5.68% |
| 2013-12-31 | 17.42% |
| 2013-09-30 | 6.97% |
| 2013-06-30 | 13.11% |
| 2013-03-31 | 17.63% |
| 2012-12-31 | 15.83% |
| 2012-09-30 | 21.93% |
| 2012-06-30 | 21.13% |
| 2012-03-31 | 22.03% |
| 2011-12-31 | 18.87% |
| 2011-09-30 | 21.86% |
| 2011-06-30 | 19.57% |
| 2011-03-31 | 21.02% |
| 2010-12-31 | 19.37% |
| 2010-09-30 | 26.62% |
| 2010-06-30 | 25.49% |
| 2010-03-31 | 24.81% |
| 2009-12-31 | 28.02% |
| 2009-09-30 | 18.84% |
| 2009-06-30 | 23.85% |
| 2009-03-31 | 23.68% |
| 2008-12-31 | 21.55% |
| 2008-09-30 | 22.03% |
| 2008-06-30 | 23.41% |
| 2008-03-31 | 23.48% |
| 2007-12-31 | 21.89% |
| 2007-09-30 | 47.41% |
| 2007-06-30 | 21.51% |
| 2007-03-31 | 21.84% |
| 2006-12-31 | 20.91% |
| 2006-09-30 | 19.66% |
| 2006-06-30 | 21.98% |
| 2006-03-31 | 16.81% |
| 2005-12-31 | 20.23% |
| 2005-09-30 | 19.83% |
| 2005-06-30 | 21.47% |
| 2005-03-31 | 20.47% |
| 2004-12-31 | 20.15% |
| 2004-09-30 | 7.22% |
| 2004-06-30 | 21.10% |
| 2004-03-31 | 18.66% |
| 2003-12-31 | 20.31% |
| 2003-09-30 | 17.97% |
| 2003-06-30 | 18.10% |
| 2003-03-31 | 18.47% |
| 2002-12-31 | 16.96% |
| 2002-09-30 | 18.37% |
